OTC sales
This article was originally published in The Tan Sheet
Executive Summary
Pharmacists should be encouraged to record OTC purchases, reason for purchase and demographic details to provide additional data for AERs and to prevent inappropriate product use, New Zealand researchers say in an editorial in the Sept. 29 British Medical Journal. David Clark, PhD, University of Otago, et al., cite Yale Hemorrhagic Stroke Project findings, growing "queue of drugs" waiting to gain OTC status as reasons for increased pharmacovigilance
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning